AF6 orchestrates macrophage polarization via JAK2-STAT3 signaling and supports intestinal regeneration by stimulating stem cell proliferation - Report - MDSpire

AF6 orchestrates macrophage polarization via JAK2-STAT3 signaling and supports intestinal regeneration by stimulating stem cell proliferation

  • By

  • Tao Jian

  • Xiaoxia Dong

  • Jingwen Kong

  • Xinyu Wang

  • Meiyan Qi

  • Lixing Zhan

  • Lilei Zhuang

  • June 19, 2026

  • 0 min

Share

AF6 regulates macrophage polarization through JAK2-STAT3 pathway

Overview

This study identifies AF6 as a regulator of macrophage polarization, influencing pro-inflammatory M1 polarization and colitis. The findings reveal that AF6 operates through the JAK2-STAT3 signaling pathway.

Background

Macrophages play a role in intestinal inflammation and repair, with their polarization states impacting inflammatory bowel disease (IBD) outcomes. Understanding the mechanisms that regulate macrophage polarization is important for developing therapies for IBD, including Ulcerative Colitis and Crohn's Disease.

Data Highlights

No numerical data or trial data provided in the source material.

Key Findings

  • AF6 promotes pro-inflammatory macrophage polarization in the context of colitis.
  • Deletion of AF6 in macrophages impairs JAK-STAT3 signaling and shifts polarization away from M1.
  • AF6-deficient macrophages enhance epithelial regeneration through increased IL-10 production.
  • AF6 expression is significantly upregulated in macrophages during inflammatory challenges.

Clinical Implications

Understanding the role of AF6 in macrophage polarization may inform future research directions in managing inflammation and tissue repair in IBD.

Conclusion

The study identifies AF6 as a regulator of macrophage polarization. Further exploration of this pathway may enhance understanding of macrophage-driven inflammation and repair mechanisms.

Related Resources & Content

  1. Frontiers in Immunology, 2026 -- Macrophage dysregulation in inflammatory bowel disease: cellular heterogeneity, pathogenic mechanism, and treatment
  2. Blood Cancer Journal, 2025 -- Targeting the NFκB/IL-6/JAK2/STAT Pathway in Myelofibrosis: Implications for Overcoming Resistance to JAK2 Inhibitors
  3. Basic Research in Cardiology, 2016 -- Interactions Between Macrophages and Atrial Myocytes in Atrial Fibrillation
  4. Official journal of the American College of Gastroenterology | ACG, 2025 -- ACG clinical guideline update: ulcerative colitis
  5. Frontiers in Immunology — Macrophages dynamically integrate neuro-immune-microbial network signals: their role in gastrointestinal motility disorders and targeting potential
  6. Official journal of the American College of Gastroenterology | ACG
  7. A meta-analysis of the efficacy and safety of Janus kinase inhibitors in patients with ulcerative colitis - PMC
  8. Frontiers | Macrophage dysregulation in inflammatory bowel disease: cellular heterogeneity, pathogenic mechanism, and treatment

Original Source(s)

Related Content